Mometasone Furoate

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

70 API Suppliers, 32 USDMF, 25 CEP/COS, 9 JDMF, 8 EU WC, 7 KDMF, 28 NDC API, 41 Listed Suppliers

DEVELOPMENTS

48 Drug(s) in Development

48 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

INTERMEDIATES

2 Suppliers

2 Suppliers

DOSSIERs // Finished Dosage Formulations

282 Dossiers, 37 FDA Orange Book, 119 Europe, 17 Canada, 59 Australia, 25 South Africa, 25 Listed Dossiers

DRUG PRODUCT COMPOSITION

OINTMENT;TOPICAL - 0.1%, CREAM;TOPICAL - 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, LOTION;TOPICAL - 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, AEROSOL, METERED;INHALATION - 0.05MG/INH, AEROSOL, METERED;INHALATION - 0.10MG/INH, AEROSOL, METERED;INHALATION - 0.20MG/INH, SPRAY, METERED;NASAL - 0.05MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, POWDER;INHALATION - 0.11MG/INH, POWDER;INHALATION - 0.22MG/INH, AEROSOL, METERED;INHALATION - 0.005MG/INH;0.05MG/INH, AEROSOL, METERED;INHALATION - 0.005MG/INH;0.1MG/INH, AEROSOL, METERED;INHALATION - 0.005MG/INH;0.2MG/INH

OINTMENT;TOPICAL - 0.1%
CREAM;TOPICAL - 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
LOTION;TOPICAL - 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
AEROSOL, METERED;INHALATION - 0.05MG/INH
AEROSOL, METERED;INHALATION - 0.10MG/INH
AEROSOL, METERED;INHALATION - 0.20MG/INH
SPRAY, METERED;NASAL - 0.05MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
POWDER;INHALATION - 0.11MG/INH
POWDER;INHALATION - 0.22MG/INH
AEROSOL, METERED;INHALATION - 0.005MG/INH;0.05MG/INH
AEROSOL, METERED;INHALATION - 0.005MG/INH;0.1MG/INH
AEROSOL, METERED;INHALATION - 0.005MG/INH;0.2MG/INH

RELATED EXCIPIENT COMPANIES

Suppliers, 10 Kerry, 9 Roquette, 8 Sigachi Industries, 7 Gangwal Chemicals, 6 Actylis, 6 Microlex e.U, 6 Seppic, 5 Gangwal Healthcare, 4 BASF, 4 Nanjing Well Pharmaceutical, 3 DFE Pharma, 2 Finar, 1 The Dow Chemical Company, 1 Ideal Cures Pvt Ltd, 1 Pharmatrans-Sanaq, 1 Jai Radhe Sales, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Nanjing Bold Chemical, 1 Vasa Pharmachem, 1 Rochem International Inc, 1 Kima Chemical, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Prachin Chemical, 1 SPI Pharma

EXCIPIENTS BY APPLICATIONS

21 Fillers, Diluents & Binders, 19 Solubilizers, 14 Direct Compression, 14 Thickeners and Stabilizers, 10 Parenteral, 8 Film Formers & Plasticizers, 8 Coating Systems & Additives, 8 Co-Processed Excipients, 7 Granulation, 7 Disintegrants & Superdisintegrants, 6 Topical, 5 Controlled & Modified Release, 4 Rheology Modifiers, 4 Emulsifying Agents, 3 Taste Masking, 3 Lubricants & Glidants, 2 Surfactant & Foaming Agents, 2 Chewable & Orodispersible Aids, 1 API Stability Enhancers